Efficacy of anti‐sebum moisturizing cream containing 2% l ‐carnitine and 5% epigallocatechin gallate in seborrhea: A randomized clinical trial
Journal of Cosmetic Dermatology · 2023
DOI: 10.1111/jocd.15816 ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift Journal of Cosmetic Dermatology, 2023. Verfasst von Pipatpong Detudom und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Dermatology, Faculty of Medicine, Srinakharinwirot University, Bangkok, Thailand. Hauptthemen laut MEDLINE: Catechin, Carnitine, Skin Cream, Sebum. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 24 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Srinakharinwirot University.
Abstract (Originalsprache)
Background
Seborrhea leads to facial greasiness and unpleasant feeling. People with seborrhea also have trouble with selecting moisturizers. l ‐Carnitine and epigallocatechin gallate (EGCG) are reported anti‐sebum properties. However, neither efficacy comparison nor the combination effect of the two topical anti‐sebum agents was studied. Moisturizing cream with these agents is supposed to provide skin with an optimal water–oil balance.
Aims
To compare the efficacy of moisturizer containing 2% l ‐carnitine or 5% EGCG alone on sebum controlling, and the synergistic effect of these two agents.
Methods
Three study creams were formulated by adding three kinds of anti‐sebum agents which were 2% l ‐carnitine, 5% EGCG, and 2% l ‐carnitine plus 5% EGCG in moisturizing cream base of dimethicone and glycerin. A randomized clinical trial was conducted. Ninety subjects, divided into three groups, applied the cream for 4 weeks. Sebum level, skin capacitance, and transepidermal water loss (TEWL) were evaluated at Weeks 0, 1, 2, and 4. Life qualities and subjective outcomes were assessed before and after treatment.
Results
The mean sebum reduction from baseline was statistically significant in all treatment groups ( p < 0.01). The median time to oil control was longer in l ‐carnitine group. The combine group had significantly greater anti‐sebum efficacy than l ‐carnitine group ( p = 0.009). All three groups had significant improvement of other objective parameters and subjective outcomes.
Conclusions
The anti‐sebum moisturizing cream exhibited beneficial effect on the sebum reduction with improve skin hydration in people with seborrhea and made users satisfied. The EGCG group and the combine group show the greater anti‐sebum effect than the l ‐carnitine group.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Dermatology, Faculty of Medicine, Srinakharinwirot University, Bangkok, Thailand.
- Department of Preventive and Social Medicine, Srinakharinwirot University, Bangkok, Thailand.
- School of Antiaging and Regenerative Medicine, Mae Fah Luang University, Bangkok, Thailand.
- Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand.
ORCID-Profile: Pipatpong Detudom, Nanticha Kamanamool, Anon Paichitrojjana, Pawat Udompataikul, Montree Udompataikul
Förderung
- Srinakharinwirot University
Zitieren
APA
Detudom, P., Kamanamool, N., Paichitrojjana, A., Udompataikul, P., & Udompataikul, M. (2023). Efficacy of anti‐sebum moisturizing cream containing 2% l ‐carnitine and 5% epigallocatechin gallate in seborrhea: A randomized clinical trial. Journal of Cosmetic Dermatology. https://doi.org/10.1111/jocd.15816
Vancouver
Detudom P, Kamanamool N, Paichitrojjana A, Udompataikul P, Udompataikul M. Efficacy of anti‐sebum moisturizing cream containing 2% l ‐carnitine and 5% epigallocatechin gallate in seborrhea: A randomized clinical trial. Journal of Cosmetic Dermatology. 2023. doi:10.1111/jocd.15816
BibTeX
@article{Detudom2023,
author = {Detudom, Pipatpong and Kamanamool, Nanticha and Paichitrojjana, Anon and Udompataikul, Pawat and Udompataikul, Montree},
title = {Efficacy of anti‐sebum moisturizing cream containing 2% l ‐carnitine and 5% epigallocatechin gallate in seborrhea: A randomized clinical trial},
journal = {Journal of Cosmetic Dermatology},
year = {2023},
doi = {10.1111/jocd.15816}
}
EUVIMED